Article
|
Open Access
Featured
-
-
News & Views |
Centrosomes grow aggresomes to clear waste
Overload of proteasomal clearance triggers formation of a large protein inclusion called the aggresome, which shares similarities with protein aggregates seen in neurodegenerative diseases such as Huntington’s. A new study uncovers how centrosome and centriolar satellite components facilitate stepwise assembly of aggresomes.
- Elisa Vitiello
- & Fanni Gergely
-
Article
| Open AccessAggresome assembly at the centrosome is driven by CP110–CEP97–CEP290 and centriolar satellites
Prosser et al. report that centriolar satellite and centrosomal proteins seed aggresomes, perinuclear inclusions of misfolded proteins, and may play a role in aggresome formation during senescence and huntingtin aggregation.
- Suzanna L. Prosser
- , Johnny Tkach
- & Laurence Pelletier
-
Letter |
Selective autophagy degrades nuclear pore complexes
Lee et al. show that, after nitrogen starvation and genetic interference with the architecture of nuclear pore complexes, nucleoporins are degraded by autophagy, constituting a quality-control step at the nuclear envelope.
- Chia-Wei Lee
- , Florian Wilfling
- & Boris Pfander
-
Article |
Mitochondrial protein-induced stress triggers a global adaptive transcriptional programme
Boos et al. show that impairing mitochondrial protein import induces a global transcriptional response to activate the ubiquitin–proteasome system and heat stress response and repress oxidative phosphorylation genes.
- Felix Boos
- , Lena Krämer
- & Johannes M. Herrmann
-
Article |
Pramel7 mediates ground-state pluripotency through proteasomal–epigenetic combined pathways
Graf et al. demonstrate that Pramel7 maintains ground-state pluripotency by repressing DNA methylation through proteasomal degradation of UHRF1, thus linking the proteasome and epigenetics with cell fate regulation.
- Urs Graf
- , Elisa A. Casanova
- & Paolo Cinelli
-
Letter |
Receptor oligomerization guides pathway choice between proteasomal and autophagic degradation
Lu et al. show that the choice between proteasomal degradation and selective autophagy is independent of the ubiquitin-binding properties of the receptors but largely determined by oligomerization potential.
- Kefeng Lu
- , Fabian den Brave
- & Stefan Jentsch
-
News & Views |
p53 mutations promote proteasomal activity
p53 mutations occur very frequently in human cancer. Besides abrogating the tumour suppressive functions of wild-type p53, many of those mutations also acquire oncogenic gain-of-function activities. Augmentation of proteasome activity is now reported as a common gain-of-function mechanism shared by different p53 mutants, which promotes cancer resistance to proteasome inhibitors.
- Moshe Oren
- & Eran Kotler
-
News & Views |
New MAPS for misfolded proteins
Clearing misfolded proteins from the cytoplasm is essential to maintain cellular homeostasis. Now, a parallel clearance system is described that uses the deubiquitylase USP19 to enable secretion of misfolded cytoplasmic proteins when conventional proteasomal degradation is compromised. Misfolding-associated protein secretion (MAPS) has important implications for protein quality control and prion-like transmission.
- Norbert Volkmar
- , Emma Fenech
- & John C. Christianson
-
Article |
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
Walerych et al. show that p53 missense mutants upregulate the proteasome and increase breast cancer cell resistance to proteasome inhibitors. Combined inhibition of p53 mutants and the proteasome leads to increased therapeutic efficacy.
- Dawid Walerych
- , Kamil Lisek
- & Giannino Del Sal
-
News & Views |
Ramping up degradation for proliferation
The control of proteasome-mediated protein degradation is thought to occur mainly at the level of polyubiquitylation of the substrate. However, the proteasome can also be regulated directly, as now demonstrated by a study in which DYRK2-mediated phosphorylation of the 19S subunit Rpt3 is found to increase proteasome activity.
- Jon M. Huibregtse
- & Andreas Matouschek
-
Article |
Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis
Dixon and colleagues and Guo and colleagues find that phosphorylation of the 19S proteasome subunit Rpt3 by DYRK2 increases proteasome activity and promotes cell proliferation, whereas loss of Rpt3 phosphorylation inhibits tumour formation in mice.
- Xing Guo
- , Xiaorong Wang
- & Jack E. Dixon
-
Article |
SCFFbxw5 mediates transient degradation of actin remodeller Eps8 to allow proper mitotic progression
Cortical actin is implicated in cell shape regulation during mitosis. Melchior and colleagues reveal that SCFFbxw5-mediated ubiquitylation and degradation of the actin remodeller Eps8 is required for timely cell rounding and progression into metaphase, whereas the capping activity of Eps8 is needed for mitotic exit.
- Achim Werner
- , Andrea Disanza
- & Frauke Melchior
-
Article |
SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma
The mTORC1 complex promotes protein translation and cell growth, whereas mTORC2 promotes survival. The Tel2 and Tt1 proteins belong to both complexes. Bassermann and colleagues demonstrate that following growth-factor deprivation, casein kinase 2 mediates phosphorylation of Tel2 and Tt1, specifically in the mTORC1 complex, to target them for degradation by the SCFFbxo9 ubiquitin ligase. This mechanism inactivates mTORC1 and activates mTORC2 and Akt signalling to promote survival of multiple myeloma cells.
- Vanesa Fernández-Sáiz
- , Bianca-Sabrina Targosz
- & Florian Bassermann
-
Article |
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
The SCF ubiquitin ligase subunit Fbxw7 is a tumour suppressor that is mutated in many cancers. Pagano and colleagues now show that in multiple myeloma, Fbxw7α instead functions as a pro-survival factor by activating the NF-κB pathway through the ubiquitin-mediated degradation of p100, an NF-κB pathway inhibitor.
- Luca Busino
- , Scott E. Millman
- & Michele Pagano
-
Article |
ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation
Wallerian degeneration occurs in axons following cutting or crush injuries; however, the molecular mechanisms that regulate this process remain elusive. Araki and colleagues find that the ubiquitin ligase ZNRF1 promotes Wallerian degeneration by ubiquitylating AKT, which leads to increased GSK3B activity and subsequent inhibition of the tubulin-binding protein CRMP2.
- Shuji Wakatsuki
- , Fuminori Saitoh
- & Toshiyuki Araki
-
Perspective |
Selective autophagy: ubiquitin-mediated recognition and beyond
- Claudine Kraft
- , Matthias Peter
- & Kay Hofmann